fp-01.1
Vaccineexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2010 (NCT01265914)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fp-01.1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02071329 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2014 | Immune Targeting Systems Ltd |
| NCT01701752 | Phase 1 | Sep 1, 2012 | Ghent University, Immune Targeting Systems Ltd |
| NCT01677676 | Phase 1 | Jan 1, 2012 | Immune Targeting Systems Ltd, INC Research, Q-Pharm |
| NCT01265914 | Phase 1 | Aug 1, 2010 | Hammersmith Medicines Research, Immune Targeting Systems Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immune Targeting Systems Ltd | For profit | 4 | 4 | 2 | 2010 |
| Ghent University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Hammersmith Medicines Research | For profit | 1 | 0 | 1 | 2010 |
| INC Research | For profit | 1 | 0 | 1 | 2012 |
| Q-Pharm | For profit | 1 | 0 | 1 | 2012 |
5 organizations
Page 1 / 1